Overview of Genotoxic Impurities in Pharmaceutical Development

This symposium focuses on the management of genotoxic impurities in the synthesis of pharmaceuticals. Recent developments in both Europe and United States require sponsors of new drug applications to develop processes to control the risks of potential genotoxic impurities. Genotoxic impurities represent a special case relative to the International Conference on Harmonisation Q3A/Q3B guidances, because genotoxicity tests used to qualify the drug substance may not be sufficient to demonstrate safety of a potentially genotoxic impurity. The default risk management approach for a genotoxic impurity is the threshold of toxicological concern unless a more specific risk characterization is appropriate. The symposium includes descriptions of industry examples where impurities are introduced and managed in the synthesis of a pharmaceutical. It includes recent regulatory developments such as the “staged threshold of toxicological concern” when administration is of short duration (eg, during clinical trials).

[1]  D. Elder,et al.  Control and analysis of alkyl and benzyl halides and other related reactive organohalides as potential genotoxic impurities in active pharmaceutical ingredients (APIs). , 2008, Journal of pharmaceutical and biomedical analysis.

[2]  Ian C. Munro Rapporteur.  Safety assessment procedures for indirect food additives: An overview: Report of a workshop , 1990 .

[3]  Nigel Greene,et al.  The application of structure-based assessment to support safety and chemistry diligence to manage genotoxic impurities in active pharmaceutical ingredients during drug development. , 2006, Regulatory toxicology and pharmacology : RTP.

[4]  E. Delaney,et al.  An impact analysis of the application of the threshold of toxicological concern concept to pharmaceuticals. , 2007, Regulatory toxicology and pharmacology : RTP.

[5]  G. Jenkins,et al.  Mechanistic influences for mutation induction curves after exposure to DNA-reactive carcinogens. , 2007, Cancer research.

[6]  Bert-Jan Baars,et al.  Risk assessment of peak exposure to genotoxic carcinogens: a pragmatic approach. , 2004, Toxicology letters.

[7]  D. Elder,et al.  Drug substances presented as sulfonic acid salts: overview of utility, safety and regulation , 2009 .

[8]  Patrick Sandra,et al.  Mechanism and Processing Parameters Affecting the Formation of Methyl Methanesulfonate from Methanol and Methanesulfonic Acid: An Illustrative Example for Sulfonate Ester Impurity Formation , 2009 .

[9]  Vernon E Walker,et al.  Biomarkers in toxicology and risk assessment: informing critical dose-response relationships. , 2008, Chemical research in toxicology.

[10]  David Q. Liu,et al.  Analytical control of genotoxic impurities in the pazopanib hydrochloride manufacturing process. , 2009, Journal of pharmaceutical and biomedical analysis.

[11]  T. McGovern,et al.  Regulation of genotoxic and carcinogenic impurities in drug substances and products , 2006 .

[12]  Gaylor Dw,et al.  Linear interpolation algorithm for low dose risk assessment of toxic substances. , 1980 .

[13]  Joel P Bercu,et al.  Quantitative assessment of cumulative carcinogenic risk for multiple genotoxic impurities in a new drug substance. , 2008, Regulatory toxicology and pharmacology : RTP.

[14]  R L Kodell,et al.  Linear interpolation algorithm for low dose risk assessment of toxic substances. , 1980, Journal of environmental pathology and toxicology.

[15]  C. Humfrey.  Recent developments in the risk assessment of potentially genotoxic impurities in pharmaceutical drug substances. , 2007, Toxicological sciences : an official journal of the Society of Toxicology.

[16]  Malcolm C. Pike,et al.  The TD50: a proposed general convention for the numerical description of the carcinogenic potency of chemicals in chronic-exposure animal experiments. , 1984 .

[17]  E. Gocke,et al.  In vivo genotoxicity of EMS: statistical assessment of the dose response curves. , 2009, Toxicology letters.

[18]  Lutz Müller,et al.  Ethyl methanesulfonate toxicity in Viracept--a comprehensive human risk assessment based on threshold data for genotoxicity. , 2009, Toxicology letters.

[19]  David Q. Liu,et al.  A practical derivatization LC/MS approach for determination of trace level alkyl sulfonates and dialkyl sulfates genotoxic impurities in drug substances. , 2008, Journal of pharmaceutical and biomedical analysis.

[20]  J. J. Bonin,et al.  Risk Assessment in Setting National Priorities , 1989, Advances in Risk Analysis.

[21]  David L. Varie,et al.  Approaches to Assessment, Testing Decisions, and Analytical Determination of Genotoxic Impurities in Drug Substances , 2009 .

[22]  Alan M. Rulis,et al.  Establishing a Threshold of Regulation , 1989 .

[23]  R. Kroes.  Structure-Based Thresholds of Toxicological Concern (TTC): Guidance for Application to Substances Present at Low Levels in the Diet , 2004, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[24]  L Edler,et al.  Risk assessment of substances that are both genotoxic and carcinogenic report of an International Conference organized by EFSA and WHO with support of ILSI Europe. , 2006, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[25]  Lutz Müller,et al.  A rationale for determining, testing, and controlling specific impurities in pharmaceuticals that possess potential for genotoxicity. , 2006, Regulatory toxicology and pharmacology : RTP.

[26]  R. W. Lutz,et al.  Statistical model to estimate a threshold dose and its confidence limits for the analysis of sublinear dose-response relationships, exemplified for mutagenicity data. , 2009, Mutation research.

[27]  T. Pfister,et al.  EMS in Viracept--initial ('traditional') assessment of risk to patients based on linear dose response relations. , 2009, Toxicology letters.

[28]  A. Bailey,et al.  A tiered approach to threshold of regulation. , 1999, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[29]  E Kennepohl,et al.  A procedure for the safety evaluation of flavouring substances. Joint FAO/WHO Expert Committee on Food Additives. , 1999, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.